8/15/2013

The European Commission, under its Seventh Framework Programme, awarded Epistem a three-year grant worth about $1.99 million to develop point-of-care tests for hepatitis C. Epistem will work on assays for its Genedrive hand-held PCR platform.

Related Summaries